RPA2 and breast carcinoma: RB1 downregulation in MCF7 breast cancer cells caused increased phosphorylation of both RPA32 and H2A.X (Supplementary Fig. S4a), although this was not associated with increased navitoclax-mediated apoptosis (not shown).